[원서] (Advances in Antiviral Drug Design 3) E. De Clercq (Eds.)-Academi…
페이지 정보
작성일 20-01-04 21:10
본문
Download : (Advances in Antiviral Drug Design 3) E De Clercq (Eds ) Academic Press Elsevier (1999).pdf
[원서] (Advances in Antiviral Drug Design 3) E. De Clercq (Eds.)-Academic Press, Elsevier (1999)
%20E%20De%20Clercq%20(Eds%20)%20Academic%20Press%20%20Elsevier%20(1999)_pdf_01.gif)
%20E%20De%20Clercq%20(Eds%20)%20Academic%20Press%20%20Elsevier%20(1999)_pdf_02.gif)
%20E%20De%20Clercq%20(Eds%20)%20Academic%20Press%20%20Elsevier%20(1999)_pdf_03.gif)
%20E%20De%20Clercq%20(Eds%20)%20Academic%20Press%20%20Elsevier%20(1999)_pdf_04.gif)
%20E%20De%20Clercq%20(Eds%20)%20Academic%20Press%20%20Elsevier%20(1999)_pdf_05.gif)
%20E%20De%20Clercq%20(Eds%20)%20Academic%20Press%20%20Elsevier%20(1999)_pdf_06.gif)
솔루션,기타,솔루션
Download : (Advances in Antiviral Drug Design 3) E De Clercq (Eds ) Academic Press Elsevier (1999).pdf( 62 )
설명
순서
LIST OF CONTRIBUTORS
Murty N. Arimilli Masanori Baba
Gilead Sciences, Inc. Foster City, California Center for Chronic Viral Diseases Kagoshima University Kagoshima, Japan Gilead Sciences, Inc. Foster City, California AnorMED Inc. Langley, British Columbia, Canada Gilead Sciences, Inc. Foster City, California Department of Medicinal Chemistry …(To be continued )
[원서] (Advances in Antiviral Drug Design 3) E. De Clercq (Eds.)-Academic Press, Elsevier (1999)
솔루션/기타
[원서] (Advances in Antiviral Drug Design 3) E. De Clercq (Eds.)-Academic Press, Elsevier (1999) , [원서] (Advances in Antiviral Drug Design 3) E. De Clercq (Eds.)-Academic Press, Elsevier (1999)기타솔루션 , 솔루션
다.